← All companies
Wave Life Sciences Ltd.
WVE - CIK 0001631574
Market cap$1.09 B
Rank#2576
SEC filings695
Wave Life Sciences Ltd. trades as WVE and has a market capitalization of $1.09 B, making it the #2576 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $42.73M, down 60.5% from the prior year and net income of -$204.38M. This page tracks Wave Life Sciences Ltd. through 695 SEC filings, with financial statements and metrics updated as new reports are filed.
Key metrics
Revenue (latest FY)$42.73MFY 2025
Net income (latest FY)-$204.38MFY 2025
Operating cash flow (latest FY)-$187.49MFY 2025
Total assets (latest FY)$638.50MFY 2025
Net margin-478.3%latest FY
Financial performance
Over the last 9 fiscal years Wave Life Sciences Ltd.'s revenue grew from $1.09M to $42.73M, a compound annual growth rate of 50.3%. Net profit margin expanded from -5097.1% to -478.3% over the same period - every figure below comes from the company's audited annual filings.
Key statistics
- Market cap
- $1.09 B
- Share price (derived)market cap / shares outstanding
- $5.68
- EPS (diluted)FY 2025
- $-1.21
- Shares outstandingas of 2026-04-22
- 0.19B
- Total equityas of 2026-03-31
- $511.73M
- Return on equity
- -39.9%
- Cash & equivalentsas of 2026-03-31
- $544.59M
- Current ratioas of 2026-03-31
- 11.26
Latest filings
| Filing | Type | Filed |
|---|---|---|
| Major company event | 8-K | 2026-05-18 |
| SCHEDULE 13G/A | - | 2026-05-13 |
| Proxy statement | DEF 14A | 2026-05-07 |
| SCHEDULE 13G/A | - | 2026-05-06 |
| PRER14A | - | 2026-05-01 |
| Annual report (amended) | 10-K/A | 2026-04-30 |
| Quarterly report | 10-Q | 2026-04-28 |
| Major company event | 8-K | 2026-04-28 |
Recent press releases
- Wave Life Sciences Reports First Quarter 2026 Financial Results ...2026-04-28
Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update - Wave Life Sciences
- Wave Life Sciences Announces Proposed Redomiciliation to the ...2026-04-15
Wave Life Sciences Announces Proposed Redomiciliation to the United States - Wave Life Sciences
- Wave Life Sciences Reports Fourth Quarter and Full Year 2025 ...2026-02-26
Wave Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Wave Life Sciences
Similar companies
The largest companies sharing Wave Life Sciences Ltd.'s SEC industry classification (pharmaceutical preparations).
Frequently asked questions
What is Wave Life Sciences Ltd.'s market cap?
Wave Life Sciences Ltd. (WVE) has a market capitalization of $1.09 B as of 2026-06-10, ranking #2576 among US-listed companies.
How much revenue does Wave Life Sciences Ltd. make?
Wave Life Sciences Ltd. reported revenue of $42.73M for fiscal year 2025, a decrease of 60.5% year over year.
Is Wave Life Sciences Ltd. profitable?
In its latest fiscal year Wave Life Sciences Ltd. reported a net loss of $204.38M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.